|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-4-12
|
|
pubmed:abstractText |
To establish the feasibility and tolerability of gefitinib (ZD1839, Iressa) with radiation (RT) or concurrent chemoradiation (CRT) with cisplatin (CDDP) in patients with advanced non-small cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1879-355X
|
|
pubmed:author |
pubmed-author:AebersoldDaniel MDM,
pubmed-author:BernierJacquesJ,
pubmed-author:BucherStephan ESE,
pubmed-author:CiernikI FrankIF,
pubmed-author:GlanzmannChristophC,
pubmed-author:LütolfUrs MUM,
pubmed-author:LippunerThomasT,
pubmed-author:LombrieserNorbertN,
pubmed-author:RiesGerhardG,
pubmed-author:RothschildSachaS,
pubmed-author:ZouhairAberrahimA
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
80
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
126-32
|
|
pubmed:meshHeading |
pubmed-meshheading:20646869-Adult,
pubmed-meshheading:20646869-Aged,
pubmed-meshheading:20646869-Antineoplastic Agents,
pubmed-meshheading:20646869-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20646869-Area Under Curve,
pubmed-meshheading:20646869-Carboplatin,
pubmed-meshheading:20646869-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:20646869-Cisplatin,
pubmed-meshheading:20646869-Drug Administration Schedule,
pubmed-meshheading:20646869-Feasibility Studies,
pubmed-meshheading:20646869-Female,
pubmed-meshheading:20646869-Humans,
pubmed-meshheading:20646869-Lung Neoplasms,
pubmed-meshheading:20646869-Male,
pubmed-meshheading:20646869-Middle Aged,
pubmed-meshheading:20646869-Quinazolines
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Gefitinib in combination with irradiation with or without cisplatin in patients with inoperable stage III non-small cell lung cancer: a phase I trial.
|
|
pubmed:affiliation |
Radiation Oncology, Zurich University Hospital, University of Zurich, Zurich, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase I
|
